A thrombotic event in a HeartMate 3 patient in the setting of secondary polycythemia.

Published in: Proceedings (Baylor University. Medical Center) (2022)

HeartMate 3 left ventricular assist device implantation is an important treatment modality in patients with advanced heart failure. Polycythemia may predispose this population to adverse events. We present a case of a thrombotic event in a HeartMate 3 patient.

Keyphrases

left ventricular assist device
heart failure
case report
left ventricular
atrial fibrillation
cardiac resynchronization therapy
acute heart failure